Cargando…
The Significance of Platelet–Albumin–Bilirubin (PALBI) Grade in Hepatocellular Carcinoma Patients Stratified According to Platelet Count
BACKGROUND: Platelet–albumin–bilirubin (PALBI) has been demonstrated to be superior to conventional Child–Pugh (C-P) grade in evaluating liver function and prognosis of HCC patients. However, both thrombocytosis and thrombocytopenia are unfavorable for HCC survival. The aim of this study was to prel...
Autores principales: | Pang, Qing, Liu, Shuangchi, Wang, Luyao, Pan, Huadong, Wang, Chunfang, Zhou, Lei, Lu, Yimin, Liu, Huichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751793/ https://www.ncbi.nlm.nih.gov/pubmed/33364830 http://dx.doi.org/10.2147/CMAR.S277013 |
Ejemplares similares
-
Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study
por: Lee, Soon Kyu, et al.
Publicado: (2019) -
Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT)
por: Ho, Connie H.M., et al.
Publicado: (2018) -
Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child–Pugh A patients treated with radical surgery: A retrospective observational study
por: Wu, Binquan, et al.
Publicado: (2019) -
Albumin-Bilirubin Grade as a Novel Predictor of Survival in Advanced Extrahepatic Cholangiocarcinoma
por: Wang, Yong, et al.
Publicado: (2018) -
Assessment in the Survival Outcome After Transarterial Chemoembolization Combined with Cryoablation for Hepatocellular Carcinoma (Diameter > 4cm) Based on the Albumin-Bilirubin Grade and Platelet-Albumin-Bilirubin grade: A Preliminary Study
por: Huang, Zhimei, et al.
Publicado: (2020)